| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/13/2004 | WO2004040003A2 Nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 05/13/2004 | WO2004039808A2 Process for the preparation of ganciclovir |
| 05/13/2004 | WO2004018467A3 Phenacyl xanthine derivatives as dpp-iv inhibitor |
| 05/13/2004 | US20040092536 Side effect reduction; muscular disorders; trauma |
| 05/13/2004 | US20040092520 Purine compounds and uses thereof |
| 05/13/2004 | US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy. |
| 05/12/2004 | EP1418170A2 Process for the preparation of optically active amino alcohols by optical resolution |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1018514B1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1149215C Phenyl Yanthine derivatives |
| 05/11/2004 | US6734187 Purine derivatives and medicaments comprising the same as active ingredient |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734180 NF-κB inhibitor comprising an indan derivative as an active ingredient |
| 05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
| 05/06/2004 | WO2004038006A2 Purine nucleosides |
| 05/06/2004 | WO2004037823A1 Purine compounds and uses thereof as cannabinoid receptor ligands |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087806 Processes for preparing 1,3-dioxolane nucleosides |
| 05/06/2004 | US20040087599 cGMP-PDE inhibitors for the treatment of erectile dysfunction |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087587 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 05/06/2004 | EP1414822A1 Improved synthesis of branched acyclic nucleosides |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 04/29/2004 | WO2004035740A2 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | WO2004035583A1 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 04/29/2004 | WO2004035132A2 Compositions and methods for inducing osteogenesis |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082571 Substituted piperazines |
| 04/29/2004 | US20040082570 Xanthine derivative and DPPIV inhibitor |
| 04/29/2004 | CA2502356A1 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | CA2501999A1 Compositions and methods for inducing osteogenesis |
| 04/29/2004 | CA2501557A1 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 04/28/2004 | EP1412354A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1153024B1 2-amino-6-anilino-purines and their use as medicaments |
| 04/28/2004 | EP0840741B1 Pna-dna chimeras and pna synthons for their preparation |
| 04/28/2004 | EP0584068B2 Method and composition for ameliorating the adverse effects of aging |
| 04/28/2004 | CN1492870A Xanthine derivative, production and use thereof as a medicament |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | CA2109796C Modulation of cellular response to external stimuli |
| 04/22/2004 | WO2004033455A2 Hemisuccinate salts of heterocyclic dpp-iv inhibitors |
| 04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
| 04/22/2004 | WO2003048161A8 A process for preparing 2,6-dichloropurine |
| 04/22/2004 | US20040077666 Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
| 04/22/2004 | US20040077665 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 04/22/2004 | US20040077645 Xanthine derivatives,production and use thereof as medicament |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1408962A1 Substituted isoindoles and the use thereof |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1146573C Novel arabinosyladenine derivatives |
| 04/21/2004 | CN1146566C 2-aryl-8-oxodihydropurine derivatives, process for producing same, medicinal conty, same, and intermediates thereof |
| 04/20/2004 | US6723868 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 04/20/2004 | US6723727 Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 04/15/2004 | WO2004031405A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | CA2501063A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/08/2004 | WO2004029579A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 04/08/2004 | WO2004029578A2 Energy transfer dyes, terminators and use thereof |
| 04/08/2004 | WO2004029054A1 Novel adenine compound and use thereof |
| 04/08/2004 | WO2004028445A2 Processes for preparing 1,3-dioxolane nucleosides |
| 04/08/2004 | WO2004018468A3 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 04/08/2004 | WO2004016613A3 Purine derivatives and their use as antiproliferative agents |
| 04/08/2004 | WO2003022209A9 Crystalline forms of valacyclovir hydrochloride |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | CA2497765A1 8-hydroxy substituted adenine compounds and uses thereof |
| 04/07/2004 | EP1404675A1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| 04/07/2004 | EP1404338A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/06/2004 | CA2084222C Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 04/01/2004 | WO2004018470A3 Crystalline solid famciclovir forms i, ii, iii and preparation thereof |
| 04/01/2004 | WO2003104440A3 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents |
| 04/01/2004 | WO2003093461A3 Genomic library of cyanophage s-2l and functional analysis |
| 04/01/2004 | WO2003041642A3 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 04/01/2004 | WO2003016563A3 Novel molecular target for neurotoxicity |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063732 Such as trans-N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride for treatment/prevention of fungal diseases |
| 04/01/2004 | US20040063727 Rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, cancer, restenosis; synthesis |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063659 Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| 04/01/2004 | US20040063147 Novel applications of acridinium compounds and derivatives in homogeneous assays |
| 03/31/2004 | EP1403254A1 Novel applications of acridinium compounds and derivatives in homogeneous assays |
| 03/31/2004 | EP1401837A1 Purine derivatives as a2b adenosine receptor antagonists |
| 03/31/2004 | EP1401836A1 Imidazo[1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 03/31/2004 | EP1401831A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| 03/31/2004 | EP1401452A1 Beta-hydroxyamine derivatives useful in the treatment of alzheimer's disease |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1143858C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |